Mycobacterium Avium Complex (MAC): Symptoms, Causes & Treatment
Mycobacterium avium complex (MAC) refers to a group of slow-growing, environmental nontuberculous mycobacteria (NTM)—primarily Mycobacterium avium and M. intracellulare—that cause opportunistic infections in humans, particularly in immunocompromised individuals and those with structural lung disease.
Transmission & Epidemiology
MAC is ubiquitous in the environment—soil, water (municipal, natural), dust, aerosols. Infection is acquired via inhalation (respiratory tract) or ingestion (GI tract), not person-to-person. It is an opportunistic pathogen: disease occurs when host defenses are breached.
- Immunocompromised hosts: Advanced HIV (CD4 <50 cells/μL), transplant recipients, immunosuppressive therapy, inherited immunodeficiencies. Disseminated MAC was an AIDS-defining illness pre-ART; now rare with early ART.
- Structural lung disease: Bronchiectasis, COPD, cystic fibrosis, prior TB, pneumoconiosis. Causes "Lady Windermere syndrome" (middle lobe/lingula predominance in older women).
- Other: Lymphadenitis in children (cervical nodes); skin/soft tissue infections; prosthetic joint infections.
Symptoms
Vary by syndrome:
- Disseminated (HIV): Fever, night sweats, weight loss, fatigue, diarrhea, abdominal pain, anemia, hepatosplenomegaly. Insidious onset.
- Pulmonary (NTM lung disease): Chronic cough, sputum, fatigue, weight loss, hemoptysis, low-grade fever. Often mimics TB or bronchiectasis exacerbation.
- Lymphadenitis: Painless, unilateral cervical lymph node swelling in children 1–5 years.
Diagnosis
Challenging; requires integration of clinical, radiographic, and microbiologic criteria (ATS/IDSA guidelines):
- Microbiology: Sputum AFB smear/culture (multiple samples), bronchoscopy with lavage, blood culture (disseminated), tissue biopsy with culture/histology.
- Radiology: HRCT chest—nodules, bronchiectasis, tree-in-bud, cavities.
- Exclusion: Rule out TB (critical), other NTM, malignancy.
Treatment
- Disseminated MAC: Clarithromycin or azithromycin + ethambutol ± rifabutin (3-drug regimen for severe immunosuppression). Continue ≥12 months + immune recovery (CD4 >100 for >6 months on ART).
- Pulmonary MAC: Macrolide (clarithromycin/azithromycin) + ethambutol + rifampin/rifabutin, 3x/week or daily, for 12 months post-culture conversion. Surgery for localized disease.
- Lymphadenitis: Surgical excision ± antibiotics.
Drug interactions are significant (macrolides/rifamycins with ART, calcineurin inhibitors). Therapeutic drug monitoring and specialist management are essential.
Prognosis
Disseminated MAC in advanced HIV carries high mortality without treatment; with ART + MAC therapy, prognosis is good. Pulmonary MAC is chronic but manageable; cure rates ~50–80% with guideline therapy. Early diagnosis and expert care optimize outcomes.
Gum Disease - Related Articles
- Canine Vaginitis: Causes, Symptoms, and Effective Treatments
- Understanding Gum Gaps (Sulcus): Causes, Symptoms & Prevention
- Understanding and Treating Inflamed Gums: A Comprehensive Guide
- Itchy Gums (Gingivitis): 11 Causes and Targeted Treatments
- Gum Abscess: Why You Shouldn't Pop It & What to Do Instead
- Homeopathic Treatment for Gum Disease: A Safe Alternative?
- Understanding Periodontal Disease: Causes, Symptoms & Prevention
